摘要
肾癌又称肾细胞癌(renal cell carcinoma,RCC),是泌尿生殖系统最常见恶性肿瘤之一,约占成人恶性肿瘤的3%左右,男女发病率比例为2∶1,中国最新统计结果[1-2]显示肾癌的发病率比10年前明显提高,目前国内外的研究还没有找到肾癌的确切病因,肾癌的诊断主要依靠影像学检查,如B超和CT,最主要的治疗方法之一为外科手术切除。
出处
《首都医科大学学报》
CAS
北大核心
2016年第4期555-557,共3页
Journal of Capital Medical University
参考文献9
-
1Ljungberg B,Campbell S C,Choi H Y,et al.The epidemiology of renal cell carcinoma[J].Eur Urol,2011,60(4):615-621.
-
2Qayyum T,Mc Ardle P A,Lamb G W,et al.Prospective study of the role of inflammation in renal cancer[J].Urol Int,2012,88(3):277-281.
-
3Lederle F A.The rise and fall of abdominal aortic aneurysm[J].Circulation,2011,124(10):1097-1099.
-
4Hinterseher I,Kuffner H,Koch R,et al.Comparison of survival rates for abdominal aortic aneurysm treatment methods[J].World J Surg,2012,36(4):917-922.
-
5Coselli J S,Conklin L D,Lemaire S A.Thoracoabdominal aortic aneurysm repair:review and update of current strategies[J].Ann Thorac Surg,2002,74(5):S1881-S1884.
-
6Derrow A E,Seeger J M,Dame D A,et al.The outcome in the united states after thoracoabdominal aortic aneurysm repair,renal artery bypass,and mesenteric revascularization[J].J Vasc Surg,2001,34(1):54-61.
-
7Marrocco-Trischitta M M,Scicchitano G,Acconcia A,et al.Management of synchronous abdominal aortic aneurysm and renal carcinoma associated with duplication of the inferior vena cava[J].J Cardiovasc Surg,2001,42(5):683-685.
-
8Veraldi G F,Tasselli S,De Manzoni G,et al.Surgical treatment of abdominal aortic aneurysm with concomitant renal cell carcinoma:a single-centre experiencewith review of the literature[J].J Cardiovasc Surg,2006,47(6):643-649.
-
9法朋燕,刘华,郑君芳,王磊,代元平,贺俊崎.NHERF3在肾癌组织中的表达变化及其意义[J].首都医科大学学报,2015,36(2):251-254. 被引量:12
二级参考文献10
-
1Znaor A, Lortet-Tieulent J, Laversanne M, et al. Interna- tional variations and trends in renal cell carcinoma inci- dence and mortality [ J ]. Eur Urol, 2015,67:519-530.
-
2Young A C, Craven R A, Cohen D, et al. Analysis of VHL gene alterations and their relationship to clinical parameters in sporadic conventional renal cell carcinoma [ J ]. Clin Cancer Res, 2009,15(24) :7582-7592.
-
3Ghosh M G, Thompson D A, Weigel R J. PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer[ J ]. Cancer Res, 2000,60 (22) : 6367- 6375.
-
4Dunbier A K, Anderson H, Ghazoui Z, et ai. Relationship between plasma estradiol levels and estrogen-responsive gene expression in estrogen receptor-positive breast cancer in postmenopausal women[J]. J Clin Oncol, 2010,28(7) : 1161- 1167.
-
5Kim H, Abd Elmageed Z Y, Ju J, et al. PDZK is a novel factor in breast cancer that is indirectly regulated by estro- gen through IGF-1R and promotesestrogen-mediated growth [J]. Mol Med, 2013,19:253-262.
-
6Kocher O, Comella N, Gilchrist A, et al. PDZKI, a novel PDZ domain-containing protein up-regulated in carcinomas and mapped to chromosome lq21, interacts with cMOAT ( MRP2), the multidrug resistance-associated protein [ J]. Lab Invest, 1999,79(9) :1161-1170.
-
7Tsuchiya N, Sato K, Akao T, et al. Quantitative analysis of gene expressions of vascular endothelial growth factor-relat-ed factors and their receptors in renal cell carcinoma [ J ]. Tohoku J Exp Med, 2001,195(2) :101-113.
-
8Ma N, Li L W, Cheng J L. Predictive value of vascular en- dothelial growth factor polymorphisms on the clinical out- come of renal cell carcinoma patients [ J ]. Oncol Lett, 2015,9(2) :651-656.
-
9Takahashi Y, Morales F C, Kreimann E L, et al. PTEN tumor suppressor associates with NHERF proteins to attenu- ate PDGF receptor signaling [ J ]. EMBO J, 2006,25 (4) : 910-920.
-
10Cheng S, Li Y, Yang Y, et al. Breast cancer-derived K172N, D301V mutations abolish NaVH exchanger regu- latory factor 1 inhibition of platelet-derived growth factor re- ceptor signaling [ J ]. FEBS Lett, 2013,587 (20) : 3289- 3295.
共引文献11
-
1李凤,谢雪梅,徐洪涛.MRI与CT对肾癌内出血的诊断价值比较[J].安徽医药,2015,19(9):1726-1729. 被引量:4
-
2陈凤婷,李杰贤,林宇峰,邹戈.IGF-1R和MP-2蛋白在肾癌组织中的表达及意义[J].海南医学院学报,2016,22(11):1152-1155. 被引量:5
-
3王勇,温元毅.肾细胞癌患者行保留肾单位手术与根治性手术的效果及生活质量比较[J].解放军医药杂志,2017,29(9):59-62. 被引量:9
-
4李清林,林建峰,林海星,吴德柱,彭娜,林雨冬.肾癌组织钠氢交换调节因子3蛋白表达量检测及其与肿瘤恶性生物学行为的关系[J].中国医师进修杂志,2018,41(2):124-128. 被引量:2
-
5业磊,佟发春,李健,王龙,赵江铭,刘毅,王健.PPARγ在肾癌细胞凋亡中的调控作用[J].昆明医科大学学报,2018,39(5):29-34. 被引量:2
-
6王旭.功能医学成像技术在肾癌诊断中的应用现状[J].中国医疗器械信息,2017,23(21):35-36. 被引量:1
-
7白利杰,黄江,沈美铖,冯旭霞.增强CT扫描联合肿瘤标志物检测在诊断肾癌中的临床价值[J].中国CT和MRI杂志,2018,16(4):101-103. 被引量:10
-
8陈继胜,吴巧,杨安桥,谢伟建,卢大儒.血清外泌体中长链RNA作为早期肾癌诊断标志物的研究[J].现代生物医学进展,2021,21(12):2201-2206. 被引量:2
-
9张莹,马兵,王林林.腹腔镜保留肾单位肾肿瘤切除治疗早期肾癌的效果及对患者肾功能的影响[J].医学临床研究,2021,38(7):1062-1064. 被引量:2
-
10周鹏,蒋瑾,周光荣.增强CT中病灶皮质衰减比在小肾肿瘤良恶性鉴别诊断中的应用研究[J].中国CT和MRI杂志,2024,22(4):116-118.
同被引文献9
-
1侯御,周为民,冷卫阳.孤立性髂动脉瘤的临床诊断与治疗策略[J].中国血管外科杂志(电子版),2017,9(1):72-74. 被引量:6
-
2武日东,石毅,李勇辉,姚陈.破裂腹主动脉瘤的诊断与治疗[J].西南医科大学学报,2017,40(4):358-360. 被引量:4
-
3邹君杰,章希炜,李林,焦元勇,蒋军,杨宏宇,马昊.破裂腹主动脉瘤开放手术与腔内治疗早期疗效的分析[J].中国血管外科杂志(电子版),2017,9(3):176-178. 被引量:8
-
4宁俊杰,何榕洲,姚陈,常光其,王深明.腹主动脉瘤合并消化系统恶性肿瘤的外科治疗策略[J].中华医学杂志,2018,98(12):944-947. 被引量:3
-
5安乾,王兵,崔文军,司江涛,王颖.腔内修复术与传统开放术对破裂腹主动脉瘤的临床疗效比较[J].东南大学学报(医学版),2018,37(3):451-454. 被引量:7
-
6张茅平,骆曦图,黄宝骏,杨澄宇.腹主动脉瘤主动脉腔内修复术后消耗性凝血功能障碍的诊断和治疗[J].介入放射学杂志,2019,28(9):900-904. 被引量:3
-
7Rui-Mei Feng,Yi-Nan Zong,Su-Mei Cao,Rui-Hua Xu.Current cancer situation in China:good or bad news from the 2018 Global Cancer Statistics?[J].Cancer Communications,2019,39(1):202-213. 被引量:853
-
8袁佳程,金炜.腹主动脉瘤的治疗方式及其研究进展[J].世界最新医学信息文摘,2018,18(88):108-109. 被引量:3
-
9吴佳,王海洋.腹主动脉瘤的发病机制研究进展[J].医学综述,2019,25(6):1110-1116. 被引量:14
-
1李萍,梁琳琅,杨威,蒋丽敏,郭时英.肾脏肿瘤切除后新发糖尿病缓解1例[J].中国实用内科杂志,2009,29(10):940-941.
-
2周怡婷,曹建民.冷冻消融术治疗肾脏肿瘤的研究进展[J].当代医学,2009,15(5):122-125.
-
3哈木拉提.吐送,帕洛克.迪力木拉提,王文光,木拉提.热夏提,王玉杰,阿布都热扎克.木塔力甫.2型糖尿病与肾细胞癌的相关性研究[J].中国临床保健杂志,2015,18(1):18-21.
-
4王波,郑军华.射频消融治疗肾癌新进展[J].上海医学,2012,35(3):256-259. 被引量:1
-
5田建卿.糖友腿肿可能是肿瘤[J].医药食疗保健,2015,0(11):15-15.
-
6王兵,程跃,朱庆国.高血压与自发性肾周血肿[J].湖北省卫生职工医学院学报,2000,13(2):36-37.
-
7金瑞霞.肾脏肿瘤超声表现[J].世界最新医学信息文摘,2012,12(11):226-226.
-
8金惠明,孙莲萍,鲍南,朱杰明.小儿结节性硬化合并颅内肿瘤[J].中华神经外科杂志,2002,18(4):265-269. 被引量:5
-
9宋文辉,郝继辉(综述),马洪顺(审校).射频消融治疗肾脏肿瘤概况[J].中国综合临床,2009,25(10):1115-1116. 被引量:3
-
10糖友腿肿谨防肿瘤[J].健康指南(中老年),2016,0(2):66-66.